Mr. Khanna (for himself and Ms. Schakowsky) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
5 U.S.C. 553(e) 15 U.S.C. 45(a) 21 U.S.C. 353, 355, 355a, 355f
and
360cc 42 U.S.C. 1395w-3a, 1396r-8
and
262
Document Citations
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Prescription Drug Price Relief Act of 2025. H.R. 3546. 119th
Cong., 1st
sess., Introduced in House May 21, 2025. https://www.govinfo.gov/app/details/BILLS-119hr3546ih.
APA
Congress, House of Representatives (2025, May 21). Prescription Drug Price Relief Act of 2025 (H.R. 3546 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr3546ih.
MLA
United States, Congress, House of Representatives. Prescription Drug Price Relief Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr3546ih. 119th Congress, H.R. 3546, Introduced in House 21 May. 2025.
Bluebook
H.R.3546 - 119th Congress (2025-2026): Prescription Drug Price Relief Act of 2025, H.R.3546, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr3546ih.
